Lisdexamfetamine Dimesylate Recall: Lannett 40 mg 100-count
Announced 2026-07-08 · FDA
FDA recall for Lisdexamfetamine Dimesylate capsules due to a labeling mix-up. A bottle labeled as 40 mg contained 30 mg. Nationwide distribution; Lot 25280726A, Exp 03/2027; 8,544 bottles affected.
| Brand | Lannett Company Inc. |
|---|---|
| Product | Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37 |
| Reason | Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg. |
| Severity | moderate |
| Units affected | 1392 |
| Distribution | Nationwide within the USA |
| Agency | FDA |
| Recall / campaign no. | Lot #: 25280726A, Exp. Date 03/2027 |
WHAT YOU SHOULD DO
- Check your bottle's lot number and expiration date: 25280726A, 03/2027.
- Do not use the product if the bottle labeled 40 mg contains 30 mg; consult your pharmacist or doctor for guidance.
- Return or dispose of the affected product per the manufacturer's or distributor's instructions; seek a replacement if offered.
- If you have questions, contact Lannett or the FDA for further guidance.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.